Context Osteoporotic fractures are an important cause of morbidity in children with
glucocorticoid-treated rheumatic disorders. Objective This work aims to evaluate the …

Arthritis, an inflammatory condition that causes pain and cartilage destruction in joints,
affects over 54.4 million people in the US alone. Here, for the first time, we demonstrated the …

Abstract The Committee on Pediatric Bone Health of the Korean Society of Pediatric
Endocrinology has newly developed evidence-based clinical practice guidelines for …

Glucocorticoid (GC) therapy is a common treatment used in rheumatic and autoimmune
diseases, owing to its anti-inflammatory and immunosuppressive effects. However, GC …

Background Glucocorticoid‐induced osteoporosis is the most common secondary cause of
osteoporosis, which increases the risk of fracture. Long non‐coding RNA telomerase RNA …

Impaired bone formation is the main characteristics of glucocorticoid (GC)-induced
osteoporosis (GIO), which can be ameliorated by tanshinol, an aqueous polyphenol isolated …

Glucocorticoid-induced osteoporosis (GIOP) is the most common form of secondary
osteoporosis, accounting for 20% of osteoporosis diagnoses. Using glucocorticoids for> 6 …

The widespread use of glucocorticoids (GCs) contributes to the effective management of
several diseases and conditions. However, it comes at a price in the case of the bones …

Purpose Accumulating evidence implicates parathyroid hormone (PTH) in the development
of osteoporosis. However, the causal effect of PTH on bone mineral density (BMD) remains …

Findings on the association between abdominal obesity and hip fracture were summarized
in a meta-analysis in 2017; however, no study has examined the dose-response association …